The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Salivary gland tumors as secondary malignancies after treatment for pediatric bone sarcoma.
J. Kreshak
No relevant relationships to disclose
C. Ferrari
No relevant relationships to disclose
G. Bacci
No relevant relationships to disclose
M. Gambarotti
No relevant relationships to disclose
S. Ferrari
No relevant relationships to disclose
M. Mercuri
No relevant relationships to disclose
A. Longhi
No relevant relationships to disclose